Structural Formula (Tar02 0001 01)
Tarpeyo Capsule, Delayed Release
Product Images NDC 81749-004
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tarpeyo (NDC 81749-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Calliditas Therapeutics Ab, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (4 mg Bottle Label)
Each delayed release capsule contains 4mg of budesonide. The recommended dosage is provided in the prescribing information. The container should be kept tightly closed, protected from moisture, and not stored above 25°C. Tarpeyo is a trademark of Callidi Therapeutics AB and its affiliates. The product is manufactured for and distributed by Calliditas Therapeutics AB in Stockholm, Sweden. The product is available in a package size of 120 capsules and is only available with a prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
